Juan Manuel Palacios-Moreno
6PUBLICATIONS
1CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Apr 22, 2021
Real-world therapeutic management and evolution of patients with benign prostatic hyperplasia in primary care and urology in Spain.Bernardino Miñana, José María Molero, Alfonso Agra Rolán
|Jul 02, 2020
Real-world assessment and characteristics of men with benign prostatic hyperplasia (BPH) in primary care and urology clinics in Spain.José María Molero, Bernardino Miñana, Juan Manuel Palacios-Moreno
|Jan 14, 2020
Men's Sexual Health Questionnaire score changes vs spontaneous sexual adverse event reporting in men treated with dutasteride/tamsulosin combination therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: A post hoc analysis of a prospective, randomised, placebo-controlled study.Claus G Roehrborn, Raymond C Rosen, Michael J Manyak
|Sep 12, 2019
Comparison of the clinical effect of dutasteride therapy for benign prostatic hyperplasia when initiated at different time points: A multicentre, observational, retrospective chart review study.Yukiko Shima, Yoshiaki Kawano, Akihiro Kobayashi
|Oct 15, 2018
Evaluation of the impact of dutasteride/tamsulosin combination therapy on libido in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH): A post hoc analysis of a prospective randomised placebo-controlled study.Raymond C Rosen, Claus G Roehrborn, Michael J Manyak
|Oct 19, 2017
A prospective randomised placebo-controlled study of the impact of dutasteride/tamsulosin combination therapy on sexual function domains in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).Claus G Roehrborn, Michael J Manyak, Juan Manuel Palacios-Moreno
Pageof 1
